sacituzumab
gilead
[' sg ', 'tropics-02']
 presents 3 month absolute improvement in os with sg compared to tpc in tropics-02 study. #asco23 
Medical Oncologist, Director of Cancer Equity & Clinical Director of Breast Oncology at Mass General Hospital; Professor, Harvard Medical School. Views my own.